Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IFNα-Kinoid in SLE
NCT02665364Phase 2Terminated
- Sponsor
- Neovacs
- Start
- Sep 2015
- Primary completion
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 21
01
Overview
A Phase 2 trial of IFN-K in systemic lupus erythematosus (SLE), sponsored by Neovacs. Started Sep 2015; status: terminated.
02
Drugs
IFN-K
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT02665364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02665364.